Iqvia Holdings (IQV) EBT Growth (3y) (2015 - 2026)
Iqvia Holdings (IQV) EBT Growth (3y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 214.22 Bn | 210.16 Bn | 8.34 Bn | 10.40% |
| 2 | Danaher | 140.38 Bn | 136.03 Bn | 3.61 Bn | -1.90% |
| 3 | Idexx Laboratories | 46.15 Bn | 45.95 Bn | 779.09 Mn | 13.42% |
| 4 | Agilent Technologies | 39.80 Bn | 37.99 Bn | 990.00 Mn | 2.67% |
| 5 | Iqvia Holdings | 39.51 Bn | 37.43 Bn | 1.44 Bn | -7.07% |
| 6 | Natera | 38.83 Bn | 37.73 Bn | 696.04 Mn | 14.73% |
| 7 | Illumina | 30.02 Bn | 28.85 Bn | 770.00 Mn | 70.10% |
| 8 | Mettler Toledo International | 28.64 Bn | 28.59 Bn | 650.22 Mn | 3.19% |
| 9 | Quest Diagnostics | 26.17 Bn | 25.54 Bn | 1.03 Bn | 9.13% |
| 10 | Labcorp Holdings | 25.90 Bn | 24.92 Bn | 1.01 Bn | 5.49% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -7.07% |
| Mar 31, 2026 | -3.23% |
| Dec 31, 2025 | 24.99% |
| Sep 30, 2025 | 4.26% |
| Jun 30, 2025 | -0.51% |
| Mar 31, 2025 | -6.88% |
| Dec 31, 2024 | 13.10% |
| Sep 30, 2024 | 8.53% |
| Jun 30, 2024 | 25.23% |
| Mar 31, 2024 | 9.78% |
| Dec 31, 2023 | 24.35% |
| Sep 30, 2023 | 50.69% |
| Jun 30, 2023 | 157.13% |
| Mar 31, 2023 | 52.53% |
| Dec 31, 2022 | 42.02% |
| Sep 30, 2022 | 73.44% |
| Jun 30, 2022 | 61.41% |
| Mar 31, 2022 | 54.25% |
| Dec 31, 2021 | 53.48% |
| Sep 30, 2021 | 74.93% |